Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
This review examines the body of evidence for GLP-1 receptor agonists (GLP-1RAs), a class of AOMs relatively frequently used in older adults, focusing on sarcopenia through mechanistic insights and clinical considerations
GLP-1 medications have quickly become some of the most talked-about treatment options for weight loss and type 2 diabetes management
The real problem is not that weight returns
The concept involves using doses significantly below the standard therapeutic range, not primarily for weight loss but for the anti-inflammatory and immune-regulatory effects
US$ 29.22
US$ 21.64
US$ 24.50
US$ 28.91
US$ 20.26
